Barclays Maintains MetLife(MET.US) With Buy Rating, Maintains Target Price $96

巴克莱银行维持大都会人寿(MET.US)买入评级，维持目标价96美元

moomoo资讯 · 01/07 17:34 · 评级/大行评级

Barclays analyst Alex Scott maintains $MetLife (MET.US)$ with a buy rating, and maintains the target price at $96.

According to TipRanks data, the analyst has a success rate of 57.1% and a total average return of 10.6% over the past year.

AnalystRecentRatingAutoNews_202978_20250107_a792f60488354b9d72ed8cfc371075298a2989ec_1736328616742626_mm_en

Furthermore, according to the comprehensive report, the opinions of $MetLife (MET.US)$'s main analysts recently are as follows:

The long-term fundamental outlook for the life insurance sector is seen as downbeat, yet the near-term prospects for stocks remain positive. Factors such as a favorable macroeconomic environment, strong balance sheets, and the capacity for share buybacks among insurers, along with current valuations, are anticipated to support further outperformance in life insurance stocks. However, a potential decline in corporate credit is viewed as a significant risk to this optimistic view.
The outlook for the insurance industry as we approach 2025 includes a more positive view on life insurers, credited to improving free cash flow, benefits derived from higher interest rates, substantial excess capital positions, robust group benefits earnings, and the potential for additional reinsurance and merger activities. Although the property and casualty sector maintains long-term quality, current challenges in property coverage underwriting and casualty loss cost trends present risks that could deter more favorable developments. Consequently, selectivity in stock selections is advised.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

巴克莱银行分析师Alex Scott维持$大都会人寿 (MET.US)$买入评级，维持目标价96美元。

根据TipRanks数据显示，该分析师近一年总胜率为57.1%，总平均回报率为10.6%。

AnalystRecentRatingAutoNews_202978_20250107_a792f60488354b9d72ed8cfc371075298a2989ec_1736328616742626_mm_sc

此外，综合报道，$大都会人寿 (MET.US)$近期主要分析师观点如下：

人寿保险行业的长期基本面前景被视为悲观，但股票的短期前景仍然乐观。有利的宏观经济环境、强劲的资产负债表和保险公司的股票回购能力等因素以及当前的估值预计将支持人寿保险股的进一步跑赢大盘。但是，企业信贷的潜在下降被视为这种乐观观点的重大风险。
临近2025年，保险业的前景包括对人寿保险公司的更加乐观的看法，这要归功于自由现金流的改善、更高的利率所带来的好处、大量的过剩资本状况、强劲的集团福利收益以及额外的再保险和合并活动的可能性。尽管财产和意外伤害行业保持了长期质量，但当前在财产保险承保和意外伤害损失成本趋势方面的挑战所带来的风险可能会阻碍更有利的发展。因此，建议选择股票。

提示:

TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。

TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。

分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。

总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

Barclays Maintains MetLife(MET.US) With Buy Rating, Maintains Target Price $96

Barclays Maintains MetLife(MET.US) With Buy Rating, Maintains Target Price $96

风险及免责提示

声明